• No results found

HIV Viremia

Patterns of HIV viremia and viral suppression before diagnosis of non-AIDS-defining cancers in HIV-infected individuals

Patterns of HIV viremia and viral suppression before diagnosis of non-AIDS-defining cancers in HIV-infected individuals

... urban, HIV-infected patients with a high prevalence of African-Americans, injection drug use and hepatitis C virus co-infection, and smoking, which is underrepresented in the ...predominant HIV risk fac- ...

7

Contribution of Follicular Dendritic Cells to Persistent HIV Viremia

Contribution of Follicular Dendritic Cells to Persistent HIV Viremia

... We cannot rule out other possible explanations for the source of third-phase viremia. For example, Althaus and De Boer (58) proposed that there exist subpopulations of latently infected cells with different ...

10

What happens to cardiovascular system behind the undetectable level of HIV viremia?

What happens to cardiovascular system behind the undetectable level of HIV viremia?

... 56 HIV positive patients and 25 controls were scanned using 82Rb PET to obtain the stress flow ...between HIV positive and negative controls ...in HIV population are not enough to con- clude the ...

17

Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia

Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia

... acute HIV infection, tightly following the viral load ...with HIV progres- sion, suggesting a cooperative role for these cytotoxic cell subsets to control HIV loads in chronic infection ...of ...

12

HLA-B*44 Is Associated with a Lower Viral Set Point and Slow CD4 Decline in a Cohort of Chinese Homosexual Men Acutely Infected with HIV-1

HLA-B*44 Is Associated with a Lower Viral Set Point and Slow CD4 Decline in a Cohort of Chinese Homosexual Men Acutely Infected with HIV-1

... in HIV-1 C subtype patients ...higher HIV-spe- cific T cell responses to a p24 pool in B*44-positive individuals, though only B*4402 and B*4403 were ...with HIV-1 ...in HIV-1 B-infected ...

7

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

... Results: We enrolled 2,044 patients, including 1,902 on HAART. Mean HAART costs were €9,377±€3,501 (range 782–29,852) per year, with remarkable site-based differences, possibly related to the different composition of ...

9

Cd8+ T Cell Effector Function And Transcriptional Regulation During Hiv Pathogenesis

Cd8+ T Cell Effector Function And Transcriptional Regulation During Hiv Pathogenesis

... acute HIV and EBV infection in humans and it is possible at least a subset of CD8 + T cells are activated non-specifically in our cohort (Doisne et ...acute HIV infection appear to express neither T-bet nor ...

154

Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients

Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients

... increasing HIV viral load (20) and qualitative and quantitative defects affecting CD4 T lymphocytes and cell-mediated immunity (11, 31, 32, 34, ...against HIV infection should thus ideally be capable of ...

5

Acute HIV revisited: new opportunities for treatment and prevention

Acute HIV revisited: new opportunities for treatment and prevention

... in HIV viremia (S72, S73) and genital- fluid shedding (27, 81, 82) occur early in acute ...of HIV transmission (83), increases in semen HIV load during acute HIV infection appear ...

10

Impact of maternal HIV 1 viremia on lymphocyte subsets among HIV exposed uninfected infants: protective mechanism or immunodeficiency

Impact of maternal HIV 1 viremia on lymphocyte subsets among HIV exposed uninfected infants: protective mechanism or immunodeficiency

... all HIV-infected pregnant women, both to pre- vent perinatal HIV transmission, and to limit possible adverse events resulting from in utero exposure to high level HIV ...

9

Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study

Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study

... of HIV RNA) suggests that even with this alternative defin- ition, there is still a gradual increase in the risk of viral re- bound with increasing blip ...

9

Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors

Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors

... the HIV-1 protein Vif (12, 26, 30, 31, 41), which prevents the incor- poration of these deaminases into budding ...are HIV-1-infected individuals who remain asymptomatic and maintain normal CD4 ⫹ ...

6

Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mou

Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2−/−γc−/− Mouse

... CCR5-tropic HIV-1 JR-CSF and monitored plasma viremia and hu-CD4 ⫹ T-cell percentage over a 4-month period ...Plasma viremia was assayed using the Abbott RealTime reverse transcription (RT)-PCR ...

5

Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral

Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy

... the HIV-1 RT region, the sensitivities of the low-level viremia genotyping and viral load assays, the lack of a placebo group to fully assess sequence evolution at viremia levels of ⬍ 50 copies/ml ...

12

Improved Single Copy Assays for Quantification of Persistent HIV 1 Viremia in Patients on Suppressive Antiretroviral Therapy

Improved Single Copy Assays for Quantification of Persistent HIV 1 Viremia in Patients on Suppressive Antiretroviral Therapy

... of HIV-1 RNA per milliliter of plasma, assuming that ...residual viremia that are below this limit of detection and thus score as undetect- able by iSCA using the standard volume of ...undetectable ...

8

Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and Production

Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and Production

... in HIV disease could be due to reduced IFN- ␣ production in response to the TRL9 ...from HIV ⫹ ...plasma HIV RNA levels ...plasma HIV RNA levels ...of HIV replication and not observed ...

11

On Optimal Control Pair Treatment: Clinical Management of
Viremia Levels In Pathogenic-Induced HIV-1 Infections

On Optimal Control Pair Treatment: Clinical Management of Viremia Levels In Pathogenic-Induced HIV-1 Infections

... In this paper, using ordinary differential equation, we propose and formulate a classical improve 3-Dimensional mathematical model, as against existing 2-Dimensional model [3], which accounts for the optimal benefits ...

9

Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.

Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.

... Using this molecular approach, we have obtained quantitative data on HIV-1 viremia levels, specific viral transcripts, and proviral sequences in infected cells; although sharp individual[r] ...

8

No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV

No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV

... on HIV patients and compatible with low seroprevalence of this infection in Irani- an healthy blood donors (0-2%) (15, ...like HIV-RNA and ...of HIV replication with HAART re- sults to restoring of ...

6

High viremia and low level of transmitted drug resistance in anti retroviral therapy naïve perinatally infected children and adolescents with HIV 1 subtype C infection

High viremia and low level of transmitted drug resistance in anti retroviral therapy naïve perinatally infected children and adolescents with HIV 1 subtype C infection

... University HIV drug resistance database ...232 HIV-1 subtype C sequences from NRTI-treated ...C HIV-1 provided the basis for our rationale for excluding these mutations from our ...

9

Show all 10000 documents...

Related subjects